APA (7th ed.) Citation

Gertz, M. A., Cohen, A. D., Comenzo, R. L., Kastritis, E., Landau, H. J., Libby, E. N., . . . Merlini, G. (2023). Birtamimab plus standard of care in light-chain amyloidosis: The phase 3 randomized placebo-controlled VITAL trial. Blood, 142(14), . https://doi.org/10.1182/blood.2022019406

Chicago Style (17th ed.) Citation

Gertz, Morie A., et al. "Birtamimab Plus Standard of Care in Light-chain Amyloidosis: The Phase 3 Randomized Placebo-controlled VITAL Trial." Blood 142, no. 14 (2023). https://doi.org/10.1182/blood.2022019406.

MLA (9th ed.) Citation

Gertz, Morie A., et al. "Birtamimab Plus Standard of Care in Light-chain Amyloidosis: The Phase 3 Randomized Placebo-controlled VITAL Trial." Blood, vol. 142, no. 14, 2023, https://doi.org/10.1182/blood.2022019406.